Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

BioTransplant and Catholic University of Louvain attempt to resolve dispute regarding MEDI-507

Feb. 4, 2003

Catholic University of Louvain to terminate agreement with BioTransplant

Feb. 3, 2003

Toray and Fujisawa to codevelop TRK-820 in Europe

Feb. 3, 2003

MBI-594AN enters phase IIb for treatment of acne

Jan. 31, 2003

Naltrexone well tolerated and effective in pruritus caused by cholestasis

Jan. 28, 2003

Two courses of alefacept evaluated in patients with chronic plaque psoriasis

Jan. 24, 2003

QRX-101 phase II trial in psoriasis cleared to begin

Jan. 24, 2003

Efficacy of TAK-427 in experimental model of atopic dermatitis

Jan. 23, 2003

Positive phase III results for Enbrel in psoriasis

Jan. 21, 2003

Tacrolimus reported safe and effective in chronic actinic dermatitis

Jan. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...